Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer
Ontology highlight
ABSTRACT: Interventions: vaccination
Primary outcome(s): safety
Study Design: Single arm Non-randomized
DISEASE(S): Unresectable Colorectal Cancer
PROVIDER: 2616206 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA